Investment Rating - The report initiates coverage with a "Buy" rating for the company [3][8]. Core Insights - The company, Leshu Shi, is a leading player in the African hygiene products market, with plans to expand into emerging markets globally. It is part of the Guangzhou Senda Group and has established a strong presence in Africa, with its core brand "Softcare" leading in sales of baby diapers and sanitary napkins [7][19]. - The African hygiene products market is expected to grow significantly, with a projected market size of USD 3.8 billion in 2024 and a CAGR of 7.9% from 2025 to 2029. Leshu Shi holds the top market share in both baby diapers (20.3%) and sanitary napkins (15.6%) [8][33]. - The company has a robust sales network and local production capabilities, which create significant barriers to entry for competitors. It has established production facilities in Africa and is expanding into Latin America and Central Asia [7][19]. - Financial projections indicate steady revenue growth, with expected revenues of USD 674 million in 2026, representing an 18.82% year-on-year increase. The net profit attributable to shareholders is projected to reach USD 143 million in the same year, with a PE ratio of 18 [6][8]. Company Overview - Leshu Shi is focused on the African market and is gradually expanding into Latin America and Central Asia. The company has been operational since 2009 and has established a strong brand presence with its "Softcare" line [19]. - The management team has extensive experience in emerging markets, with significant ownership stakes held by executives and employees, fostering a motivated organizational culture [23][25]. Industry Analysis - The African hygiene products market is characterized by high growth potential and significant barriers to entry. The population growth and increasing penetration rates in the market are expected to drive expansion [33][37]. - The competitive landscape in Africa is fragmented, with high entry barriers due to the diverse and dispersed population across the continent. This presents challenges for new entrants, particularly large international companies [52].

Investment Rating - The report maintains an "Outperform" rating for Softcare [2][3][10]. Core Insights - Softcare's 2025 results exceeded expectations, with revenue of US$567.4 million, up 24.9% YoY, and net profit of US$121.2 million, up 27.4% YoY [4][18]. - The company is expected to achieve revenue of US$6,736 million, US$7,792 million, and US$8,963 million in 2026-2028, with respective growth rates of 18.7%, 15.7%, and 15.0% [3][17]. - The US-Iran conflict is disrupting supply chain costs but is expected to accelerate industry consolidation, allowing Softcare to gain market share through localized manufacturing [6][20]. Financial Performance - In 2025, gross margin improved to 35.9%, with baby diapers and pull-up pants contributing 78.6% of total revenue [4][18]. - The company reported a return on equity (ROE) of 19.0% and maintained a payout ratio of approximately 45% [5][19]. - Operating efficiency improved, with inventory turnover days decreasing from 141 to 132 [5][19]. Regional Performance - Revenue from East Africa grew 23.9% YoY to US$256.1 million, while West Africa saw an 18.4% increase to US$230.9 million [4][18]. - Latin America revenue surged 134.3% YoY to US$22.0 million, supported by new factories in Peru and El Salvador [4][18][22]. Strategic Focus - The company emphasizes market share over short-term profits, with a clear strategy for product upgrades and channel expansion [8][21]. - The "Million-Outlet Plan" aims to expand from 3,000 distributors to direct control over one million small stores [8][21]. - Management is confident in establishing a strong foothold in Latin America within 2-3 years, leveraging local manufacturing and regional strategies [22].

Investment Rating - The report maintains an "Outperform" rating for Softcare [2][3][10]. Core Insights - Softcare's 2025 results exceeded expectations, with revenue of US$567.4 million, up 24.9% YoY, and net profit of US$121.2 million, up 27.4% YoY [4][18]. - The company is expected to achieve revenue of US$6,736 million, US$7,792 million, and US$8,963 million in 2026-2028, with respective growth rates of 18.7%, 15.7%, and 15.0% [3][17]. - The US-Iran conflict is disrupting supply chain costs but is expected to accelerate industry consolidation, allowing Softcare to gain market share through localized manufacturing and supply chain advantages [6][20]. Financial Performance - In 2025, gross margin improved to 35.9%, with baby diapers and pull-up pants contributing significantly to revenue [4][18]. - The company reported a return on equity (ROE) of 19.0% and maintained a payout ratio of approximately 45% [5][19]. - Operating efficiency improved, with inventory turnover days decreasing from 141 to 132 [5][19]. Regional Performance - Revenue from East Africa grew 23.9% YoY to US$256.1 million, while West Africa saw an 18.4% increase to US$230.9 million [4][18]. - Latin America revenue surged 134.3% YoY to US$22.0 million, supported by new factories in Peru and El Salvador [4][18]. Strategic Focus - The company emphasizes market share over short-term profits, with a clear strategy for product upgrades and channel expansion [8][21]. - The "Million-Outlet Plan" aims to expand from 3,000 distributors to direct control over one million small stores [8][21]. - Management is confident in establishing a strong foothold in Latin America within 2-3 years, leveraging local manufacturing and regional strategies [9][22].

Investment Rating - The report assigns a "Buy" rating for the company, indicating a positive outlook for future performance [1][3]. Core Insights - The company, a leading brand in diapers and sanitary pads in Africa, is expected to replicate its success in the Latin American market. The 2025 performance exceeded expectations, with a revenue increase of 25% year-on-year, driven by strong growth in the Latin American region [1][3]. - The forecast for net profit attributable to the parent company for 2026 and 2027 has been revised upwards to USD 141 million and USD 165 million, respectively, reflecting a year-on-year growth of 16% and 17% [3]. - The company achieved a total revenue of USD 567.39 million in 2025, with a net profit of USD 121.16 million, marking a year-on-year increase of 27.39% [8][9]. Financial Projections - Total revenue is projected to grow from USD 454.39 million in 2024 to USD 919.14 million by 2028, with a compound annual growth rate (CAGR) of approximately 14.23% [1][9]. - The net profit is expected to increase from USD 95.11 million in 2024 to USD 189.77 million in 2028, reflecting a CAGR of about 14.88% [1][9]. - The earnings per share (EPS) is forecasted to rise from USD 0.15 in 2024 to USD 0.31 in 2028, indicating a strong growth trajectory [1][9]. Segment Performance - The baby care segment reported revenue of USD 446 million in 2025, with a year-on-year growth of 23.1%, driven by a significant increase in sales volume and average selling price [8][9]. - The female care segment achieved revenue of USD 99 million, growing by 27.9% year-on-year, supported by demographic trends and government initiatives [8][9]. - The family care segment saw a remarkable revenue increase of 53.8%, indicating strong demand and effective channel expansion [8][9]. Regional Performance - Revenue from the Latin American market grew by 134.3%, showcasing the company's successful expansion efforts in this region [8][9]. - The company reported revenues of USD 2.56 million from East Africa, USD 2.31 million from West Africa, and USD 0.58 million from Central Africa, with respective year-on-year growth rates of 23.9%, 18.4%, and 34.5% [8][9].

Investment Rating - The report assigns a "Buy" rating for the company, indicating a positive outlook for future performance [1][3]. Core Insights - The company, a leading brand in Africa for diapers and sanitary pads, is expected to replicate its success in the Latin American market. The 2025 performance exceeded expectations, with a revenue increase of 24.9% year-on-year [3]. - The report highlights significant growth in the Latin American region, with projections for net profit revisions for 2026 and 2027 increased to $141 million and $165 million, respectively, reflecting year-on-year growth of 16% and 17% [3]. - The company achieved a total revenue of $567.39 million in 2025, surpassing the expected $500 million, driven by currency appreciation against the US dollar and a 4-7% increase in average selling prices [8]. Financial Projections - Total revenue is projected to grow from $454.39 million in 2024 to $919.14 million by 2028, with a compound annual growth rate (CAGR) of approximately 14.23% [1][9]. - Net profit is expected to rise from $95.11 million in 2024 to $189.77 million in 2028, indicating a strong growth trajectory with a CAGR of around 14.88% [1][9]. - The earnings per share (EPS) is forecasted to increase from $0.15 in 2024 to $0.31 in 2028, reflecting a positive trend in profitability [1][9]. Segment Performance - The baby care segment reported revenue of $446 million in 2025, a year-on-year increase of 23.1%, with sales volume reaching 5.43 billion pieces, up 17.9% [8]. - The female care segment generated $99 million in revenue, growing by 27.9%, driven by an increase in the target population and government initiatives in Africa [8]. - The household care segment saw a remarkable revenue increase of 53.8%, reaching $22 million, with a sales volume of 2.29 billion pieces [8]. Regional Performance - Revenue from the Latin American market grew by 134.3%, indicating strong market penetration and expansion efforts [8]. - Revenue contributions from East Africa, West Africa, and Central Africa were $256 million, $231 million, and $58 million, respectively, with year-on-year growth rates of 23.9%, 18.4%, and 34.5% [8]. Profitability Metrics - The company achieved a gross margin of 35.9% in 2025, an increase of 0.6 percentage points year-on-year, attributed to favorable currency exchange rates and product mix improvements [8]. - The net profit margin stood at 21.4%, reflecting a slight increase of 0.5 percentage points from the previous year [8].

Summary of the Conference Call Company and Industry Overview - **Company**: Leshu Shi Group - **Industry**: Fast-Moving Consumer Goods (FMCG) focusing on hygiene products in Africa and Latin America Key Points and Arguments Long-term Growth Potential in Africa - Africa's population of eligible female consumers is expected to reach 800 million in 15-20 years, double that of China, with current penetration rates around 20% and low per capita consumption compared to mature markets, indicating significant growth potential [2][4][5] Financial Performance for FY 2025 - Group revenue reached $567 million, a 24.9% increase year-over-year - Net profit was $121 million, also up 27%, with a stable gross margin around 35% and a return on equity (ROE) of 19% [2][6] Competitive Advantages - The company employs a "Three Outs" localization model, producing locally to avoid trade restrictions and customizing products for African habits, pricing them 15% lower than international brands while maintaining profitability [2][5] - Strong understanding of local markets and long-term presence in Africa since 1997 provides a competitive edge [4][5] Product Line Optimization - Baby care products account for 79% of revenue, with a 23% increase; sanitary napkin sales grew 28%, and wet wipes saw a 53% increase, indicating a shift in revenue contribution with sanitary napkins becoming a significant growth driver [2][7] Global Expansion and Capacity Growth - Production lines increased from 48 to 66, with West and East Africa contributing 85% of revenue; new capacities in Latin America (El Salvador, Peru) are expected to double growth potential [2][8] Supply Chain Resilience - Global procurement and onshore factories mitigate risks from geopolitical tensions; shipping costs are locked in at a 40% discount [3][19] Market Characteristics in Africa - Africa's macro environment features high population growth, a youthful demographic, and low product penetration rates, providing a long-term consumption drive [4][5] Financial Metrics and Cost Structure - Gross margins remained stable at around 35%, with baby care margins between 33-35% and sanitary napkins above 40% [8][10] Future Investment Plans - Total assets grew from $250 million in 2020 to approximately $760 million in 2025, with significant investments in production capacity and cash reserves reaching $450 million [9][10] Operational Efficiency - Accounts receivable turnover is around 45 days, and inventory turnover improved from 141 to 132 days, indicating enhanced supply chain management [10] Strategic Differentiation - The company differentiates itself through localized production and a deep understanding of African markets, aiming to build a national brand rather than just competing on price [11][27] Marketing and Channel Strategy - Plans to implement a "Million Terminal" strategy to deepen distribution channels, focusing on local partnerships and digital transformation [12][23] Currency Risk Management - The company employs a "cash in advance" model and maintains a diversified market presence to mitigate currency risks, with over 40% of revenue from stable currencies [20][21] Future Outlook - The company anticipates continued growth in emerging markets, with a target of mid-teens annual growth, particularly in Africa and Latin America [24][25] Competitive Landscape - The company has successfully competed against major global brands in Africa, with no immediate threats from new entrants due to the high barriers to entry [26] Product Strategy - Focus on high-quality, locally adapted products that meet the specific needs of African consumers, with plans to expand into multiple brands over time [27][28] Expansion in Latin America - The company is optimistic about its growth in Peru and El Salvador, with plans to leverage local manufacturing to serve surrounding markets [29] Local Talent Development - Initiatives are in place to cultivate local talent in Africa, enhancing operational effectiveness and brand presence [30] Impact of Geopolitical Events - Recent geopolitical tensions have presented more opportunities than risks, with stable supply chains and favorable shipping contracts [19][30] This summary encapsulates the key insights and strategic directions discussed during the conference call, highlighting the company's robust growth trajectory and competitive positioning in the FMCG sector, particularly in emerging markets.

Investment Rating - The report assigns a "Buy" rating to the company with a current price of HKD 29.82 and a fair value of HKD 39.24 [4]. Core Insights - The company, Leshu Shi, is a leading player in the sanitary products market in emerging markets, particularly in Africa, with a market share of 20% in baby diapers and 16% in sanitary napkins as of 2024 [8]. - The company has established a strong operational presence with eight factories and 18 sales branches across over 30 countries, indicating robust market penetration [8]. - The African sanitary products industry is expected to grow steadily, driven by population growth and economic development, with a compound annual growth rate (CAGR) of 6.8% from 2020 to 2024 [8]. - Leshu Shi has built high barriers to entry through local production and deep channel management, positioning itself as a leader in the market [8]. - The company aims to expand into Latin America and diversify its product offerings, leveraging its existing distribution channels [8]. - Profit forecasts indicate a net profit of USD 1.41 million in 2026, growing to USD 1.86 million by 2028, reflecting a strong growth trajectory [8]. Financial Summary - The company’s revenue is projected to grow from USD 454 million in 2024 to USD 875 million by 2028, with growth rates of 10.5% in 2024 and 24.9% in 2025 [2]. - EBITDA is expected to increase from USD 124 million in 2024 to USD 226 million in 2028, indicating improving profitability [2]. - Non-GAAP net profit is forecasted to rise from USD 98 million in 2024 to USD 186 million in 2028, with a growth rate of 24.4% in 2025 [2]. - The company’s Non-GAAP EPS is projected to increase from HKD 0.20 in 2025 to HKD 0.30 in 2028 [2]. - The Non-GAAP PE ratio is expected to decrease from 20.9 in 2025 to 12.7 in 2028, suggesting an attractive valuation [2]. Market and Industry Analysis - The report highlights the favorable macroeconomic factors in Africa, including a growing eligible population and rising GDP, which support the demand for sanitary products [8]. - The industry is characterized by a concentrated market structure, with Leshu Shi holding a leading position in both baby diapers and sanitary napkins [8]. - The company’s strategy includes enhancing its distribution network and product offerings to capture a larger market share [8].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 44 HKD [6][5]. Core Insights - The company reported a revenue of 567 million USD for 2025, representing a year-on-year increase of 24.9%, and a net profit of 121 million USD, up 27.4%, exceeding expectations due to business expansion and favorable currency exchange rates [1][5]. - The company benefits from high population growth and low penetration rates in emerging markets, with a strong cash reserve post-IPO to support local production capacity [1][4]. - The company has seen significant growth across all product categories, with baby care, feminine care, and family care revenues increasing by 23.1%, 27.9%, and 53.8% respectively [2]. Summary by Sections Revenue and Profitability - Revenue for 2025 was 567 million USD, with a net profit of 121 million USD, both showing substantial growth compared to the previous year [1]. - Adjusted net profit was 122 million USD, reflecting a 24.4% increase year-on-year [1]. Product Performance - Revenue breakdown for 2025 shows baby care at 446 million USD, feminine care at 99 million USD, and family care at 22 million USD, with all categories experiencing volume and price increases [2]. - The company’s brands, Softcare and Veesper, have seen an increase in revenue contribution, indicating a shift towards mid-to-high-end market positioning [2]. Geographic Performance - Revenue from East Africa, West Africa, Central Africa, and Latin America reached 256 million USD, 231 million USD, 58 million USD, and 22 million USD respectively, with Latin America showing a remarkable growth of 134.3% [2]. Profit Margins - The gross margin for 2025 was 35.9%, a 0.7 percentage point increase, driven by favorable exchange rates and product upgrades [3]. - The net profit margin stood at 21.4%, reflecting a 0.4 percentage point increase year-on-year [3]. Cash Flow and Capital Expenditure - The company generated 115 million USD in operating cash flow and had a cash balance of 445 million USD at year-end, supporting ongoing capacity expansion [4]. - Capital expenditures for the year included the construction of a new factory and 18 production lines, totaling 52 million USD [4]. Future Outlook - The company has adjusted its net profit forecasts for 2026 and 2027 upwards by 5% and 3% respectively, anticipating continued growth driven by market expansion [5]. - The expected earnings per share (EPS) for 2026, 2027, and 2028 are projected at 0.23, 0.26, and 0.30 USD respectively [5].

Investment Rating - The report maintains a "Recommended" rating for the company, indicating an expectation that the stock will outperform the market by 10% to 20% over the next six months [10]. Core Insights - The company achieved a revenue of $567 million in 2025, representing a year-over-year growth of 24.9%, with a net profit of $121 million, up 27.4% from the previous year [3][6]. - The company plans to distribute a final dividend of $0.0888 per share for the fiscal year ending December 31, 2025 [3]. - The company is experiencing significant growth in emerging markets, particularly in Africa and Latin America, driven by increasing population, urbanization, and health awareness [6][7]. Financial Performance Summary - Revenue projections for the upcoming years are as follows: $666 million in 2026, $776 million in 2027, and $900 million in 2028, with year-over-year growth rates of 17.4%, 16.4%, and 16.0% respectively [5]. - Net profit is expected to grow to $142 million in 2026, $166 million in 2027, and $194 million in 2028, with corresponding growth rates of 17.1%, 17.1%, and 16.6% [5]. - The gross margin for 2025 is reported at 35.9%, with a slight increase projected in subsequent years [5][8]. Market and Regional Analysis - The company has successfully expanded its sales channels in emerging markets, maintaining a leading position in core markets, with significant revenue contributions from baby care ($446 million), women's care ($99 million), and household care ($22 million) [6]. - The Latin American market showed remarkable growth, with a year-over-year increase of 134.3%, while the African market also demonstrated resilience with growth rates of 23.9% in East Africa and 18.4% in West Africa [6][7]. Strategic Positioning - The company leverages local manufacturing, deep distribution networks, and brand recognition as core competitive advantages, optimizing its production capacity in key regions [6][7]. - The report highlights the company's strategic clarity and strong barriers to entry, suggesting a broad long-term growth potential in the hygiene products sector [6][7].

Group 1 - The company reported a 3.9% year-on-year revenue growth in the second half of 2025, reaching 11 billion RMB, with a net profit increase of 31% to 1.1 billion RMB, outperforming both the bank and market expectations [1] - Excluding foreign exchange gains and losses, the estimated net profit growth for the second half of the year is 21% year-on-year [1] - The company's tissue and hygiene products business saw a sales increase of 8% year-on-year in the second half, accelerating from 3% growth in the first half [1] Group 2 - The management indicated that the tissue business volume grew by approximately 5% in 2025, benefiting from an improved high-end product mix and a 1 percentage point increase in average price [1] - Although sales volume in hygiene products declined, this was offset by an increase in average price [1] - The overall gross margin improved by 4 percentage points year-on-year and 3 percentage points quarter-on-quarter to 35.5%, aided by lower raw material prices and increased sales of high-margin products [1] Group 3 - The management expects continued intense competition in the hygiene products industry in 2026, planning to shift towards mid-to-high-end products to avoid price wars [1] - While wood pulp prices are expected to stabilize, management is concerned about supply chain uncertainties and raw material price increase risks due to conflicts in the Middle East [1] - Expansion into international markets and new product categories is anticipated to be the two main growth engines for sales over the next five years [1] Group 4 - UBS maintained a "Buy" rating for the company, raising profit forecasts for 2026 to 2028 by 4% to 9% based on strong performance in the second half of last year and better-than-expected high-end product performance [2] - The target price was increased from 32.5 HKD to 34.9 HKD, based on discounted cash flow valuation, equivalent to a projected price-to-earnings ratio of 14 times for 2026 [2] - The current price corresponds to a projected price-to-earnings ratio of 11 times for 2026, with an expected dividend yield of 6% [2]